22 Amendments of Julie GIRLING related to 2012/2066(INI)
Amendment 12 #
Motion for a resolution
Citation 19 a (new)
Citation 19 a (new)
- having regard to the definition for endocrine disrupting chemicals developed by the World Health Organisation (WHO) and the International Programme on Chemical Safety (IPCS)1; __________________ 1 Definition from the WHO/IPCS (2002) report: "An endocrine disruptor is an exogenous substance or mixture that alters function(s) of the endocrine system and consequently causes adverse health effects in an intact organism, or its progeny, or (sub)populations." A potential endocrine disruptor is "an exogenous substance or mixture that possesses properties that might be expected to lead to endocrine disruption in an intact organism, or its progeny, or (sub)populations." (http://www.who.int/ipcs/publications/en/c h1.pdf)
Amendment 20 #
Motion for a resolution
Recital D – introductory part
Recital D – introductory part
D. whereas, in the case ofa causal link has not yet been established between certain chemicals withand endocrine- disrupting properties, the difficulties of proving a causal link are exacerbaton, scientific research in this field has been challenged by a number of factors, such as that:
Amendment 24 #
Motion for a resolution
Recital D – indent 3
Recital D – indent 3
– during their lives, people are exposed to a large number of chemicalnatural and synthetic chemicals, sometimes in complex mixtures;
Amendment 26 #
Motion for a resolution
Recital D – indent 5
Recital D – indent 5
– endocrine disrupters can act at extremely low concentrations and thusaccording to some in vitro evidence, some substances could act at extremely low concentrations, however there is not yet any evidence in vivo testing of causeing adverse effects at a low dosage; where the dose-response relationship is non-monotoniclinear the difficulty of prediction increases still further;
Amendment 33 #
Motion for a resolution
Recital E a (new)
Recital E a (new)
E a. whereas any invocation of the precautionary principle should be in accordance with criteria outlined in the Commission's communication (COM(2000)0001)
Amendment 35 #
Motion for a resolution
Recital F
Recital F
F. whereas, as things stand at present, it is not legally possible to consider combination effects between endocrine disruptors released by products governed by different sets of regulations, which can be addressed by a regulatory risk management;
Amendment 38 #
Motion for a resolution
Recital G
Recital G
G. whereas the standard data requirements in certain EU chemicals legislation do not contain any information on endocrine- disrupting properties;
Amendment 41 #
Motion for a resolution
Paragraph 1
Paragraph 1
1. Considers, on the basis of an overall assessment of the state of knowledge, that the precautionary principle requires us as legislators to take measures to reduce human exposure to endocrine disruptors to a minimumlegislators should take measures to establish principles to assess the risk posed by endocrine disruptors and to reduce human exposure to a minimum; emphasises that this approach requires further scientific research into possible endocrine disrupting chemicals;
Amendment 51 #
Motion for a resolution
Paragraph 2
Paragraph 2
2. Takes the view that the feared effects of endocrine disruptors are so serious that the absence of precise knowledge, including exact knowledge of a causal links, should not prevent us from tak between exposure to chemicals and endocrine disruption, requires us to consider other possible causes of endocrine disruption, such as age, lifestyle and other environmental factors, when developing measures to protect humans and animals;
Amendment 60 #
Motion for a resolution
Paragraph 3
Paragraph 3
3. Calls, therefore, on the Commission to submit as soon as possible proposals for overarching criteria together with testing and information requirements for chemicals on the commercial market, and for EU legislation to make clearapply the World Health Organisation's definition of what is regarded as a substance with endocrine- disrupting properties; advocates considering the introduction of ‘endocrine disruptor’ as a regulatory hazard classnd submit proposals for comprehensive criteria for their identification;
Amendment 65 #
Motion for a resolution
Paragraph 4
Paragraph 4
4. Stresses that it is important foressential that the criteria for endocrine-disrupting chemicals to be based on robust scientific evidence science and a comprehensive hazardrisk assessment;
Amendment 74 #
Motion for a resolution
Paragraph 5
Paragraph 5
5. Takes the view that that the criteria for defining endocrine disruptors should be based on criteria for defining ‘'adverse effect’' and ‘'endocrine mode of action’'; considers that both these criteria must be weighed up in parallel in order to carry out a comprehensive assessment; considers that proven effects should be assumed to be harmful as long as there is no scientific data to indicate the opposite; stresses that any possible combination effects should be taken into considerationdemonstrated to be harmful;
Amendment 80 #
Motion for a resolution
Paragraph 6
Paragraph 6
6. Stresses that the criteria determining what constitutes an endocrine disruptor shouldmust be scientifically based and that the precautionary principle should be appliedshould aim to identify those substances of regulatory concern; considers that a socio- economic assessment should then be carried out in accordance with the relevant legislation;
Amendment 84 #
Motion for a resolution
Paragraph 7
Paragraph 7
7. Takes the view that, in assessing whether a substance does or does not have endocrine-disrupting properties, all peer- reviewed scientific studies should be taken into account, subject to their strengths and weaknesses, in assessing whether a substance does or does not have endocrine-disrupting properties according to objective quality criteria; further considers it important to take account of modern methods and up-to- date research;
Amendment 87 #
Motion for a resolution
Paragraph 8
Paragraph 8
8. Calls on the Commission to introduce in all relevant EU legislation appropriate testing requirements, once it has compiled a set of robust, science-based criteria for the identification of substances with endocrine-disrupting properties, to develop testing requirements for their identification; considers that the validated and internationally recognised testing methods that have been developed in (for example) the OECD must be implemented; notes that the OECD programme of testing methods covers sex hormones and thyroid hormones as well as steroidogenesis; points out, on the other hand, that there are no tests for other areas of the endocrine system, e.g. insulin and growth hormones; considers that testing methods and guidance documents should be developed so as to take better account of endocrine disruptors, possible low-dose effects and non- monotoniclinear dose-response relationships;
Amendment 95 #
Motion for a resolution
Paragraph 9
Paragraph 9
Amendment 102 #
Motion for a resolution
Paragraph 10
Paragraph 10
10. Calls on the Commission, in its review of EU strategy on endocrine disruptors, to place greater emphasis on the precautionary principle and work towardsa risk-based approach with a view to reducing human exposure to endocrine disruptors;
Amendment 112 #
Motion for a resolution
Paragraph 12
Paragraph 12
12. Calls on the Commission to carry out a systematic examination of all relevant current legislation and, where necessary, to propose new legislation so as to reduce the exposure of human beings, particularly foetuses, babies, children and teenagers, to hormone disruptors; calls on the Commission to submit legislative proposals for chemicals in textiles and building materials, and stresses in particular the importance of reviewing legislation on materials and products intended to come into contact with food, so as to reduce human exposure to endocrine disruptorsonsider relevant current legislation as part of the current strategy;
Amendment 125 #
Motion for a resolution
Paragraph 13
Paragraph 13
13. Takes the view that endocrine disruptors shthe Commission should identify those endocrine disruptors which, by virtue of their potency or the specificity or severity of their effect, could be regarded as Substances of Very High Concern within the meaning of the Reach ReguEACH Regulation, or the equivalent under other legislation; considers, therefore, that endocrine disruptors should be subject to authorisation or restriction with a view to substitutionbased on robust scientific evidence and a risk assessment;
Amendment 128 #
Motion for a resolution
Paragraph 13 a (new)
Paragraph 13 a (new)
13 a. Takes the view that for substances which, by virtue of their low potency or severity, are not identified as SVHCs or the equivalent, appropriate risk management measures should be considered as a means to mitigate the risk posed to humans and animals;
Amendment 131 #
Motion for a resolution
Paragraph 14
Paragraph 14
14. Stresses thatAccepts that some substances identified as endocrine disruptors should currently be regarded as substances for which it is not yet possible to set a limit value at which effects may occur (‘'non- threshold’' substances) and that any exposure to such substances may entail a risk; stresses that until there is sufficient scientific information identifying the level of exposure which entails a significant risk, appropriate risk management measures as outlined in paragraph 13a should be considered;
Amendment 152 #
Motion for a resolution
Paragraph 17
Paragraph 17
17. Calls on the Commission to ensure that in developing the criteria for identifying endocrine disruptors are applied, it should consider the possible future requirement to apply these horizontally to all currentexisting and future legislation and the need to ensure consistency between different legislative acts;